Rdg. Neely et al., FAILURE OF COMPLETE SUPPRESSION OF ENDOGENOUS GLUCOSE-PRODUCTION BY EUGLYCEMIC HYPERINSULINEMIA IN NORMAL HUMANS, European journal of clinical investigation, 25(6), 1995, pp. 447-453
Citations number
40
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
In normal subjects, endogenous glucose production (EGP) is usually ass
umed to be completely suppressed during euglycaemic clamp studies perf
ormed at high insulin levels (> 100 mU L(-1)). However, this assumptio
n is based on non-steady-state tracer measurements of EGP which are pr
one to negative errors. We have used purified [6-(3) H]glucose in an o
ptimal tracer infusion protocol to assess the suppression of EGP durin
g 3 h euglycaemic clamps in eight normal men. An insulin infusion rate
of 5 mU kg(-1) min(-1) was chosen to achieve supraphysiological (>500
mU L(-1)) plasma insulin concentrations. Using a labelled exogenous g
lucose infusion, plasma glucose (mean +/- SEM 5.3 +/- 0.1 mmol L(-1))
and glucose specific activities (mean 100 +/- 3% of basal) were mainta
ined constant from 80 to 240 min. During hyperinsulinaemia, isotopical
ly determined glucose appearance rates (Ra) were greater than glucose
infusion rates (GIR) throughout the euglycaemic clamp period (P < 0.00
1) and EGP (Ra-GIR) was always greater than zero. In seven of the eigh
t; subjects studied EGP was partly suppressed but showed a wide variat
ion (EGP 5 to 91% of basal at 80-120 min and 12 to 87% of basal at 200
-240 min) while in one subject EGP rose above basal (by 72% at 80-120
min and 49% at 200-240 min). We conclude that EGP is not completely su
ppressed during euglycaemic clamps at high insulin levels.